Precipio (PRPO)

• Market cap: $38.7M
• 1 day: 2.17%
• 5 days: -8.88%
• 1 month: -12.56%
• 3 months: -29.94%
• 6 months: -12.53%
• Year to date: -9.11%
• 1 year: 51.82%
• 5 years: -65.08%
• 10 years: -99.31%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Employees: 71